Cite
MLA Citation
Gautam Borthakur et al.. “A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia.” Cancer, vol. 127, no. 16, 2021, pp. 2943–2953. http://access.bl.uk/ark:/81055/vdc_100136731233.0x000060